Response to the letter to the editor regarding “Mobile phone use and brain tumour risk − COSMOS, a prospective cohort study”

• Maria Feychting,
• Joachim Schüz,
• Mireille B. Toledano,
• Roel Vermeulen,
• Anssi Auvinen,
• Aslak Harbo Poulsen,
• Isabelle Deltour,
• Rachel B. Smith,
• Joel Heller,
• Hans Kromhout,
• Anke Huss,
• Christoffer Johansen,
• Giorgio Tettamanti,
• Paul Elliott

Affiliations

Maria Feychting

Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Corresponding authors at: Maria Feychting, Institute of Environmental Medicine, Box 210, SE-17177 Stockholm, Sweden (M. Feychting). Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, White City campus, 80 Wood Lane, London W12 0BZ, UK (P. Elliott).

Joachim Schüz

International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France

Mireille B. Toledano

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Medical Research Council (MRC) Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; National Institute for Health Research (NIHR) Health Protection Research Unit in Chemical and Radiation Threats and Hazards, Imperial College London, London, UK; Mohn Centre for Children’s Health and Wellbeing, School of Public Health, Imperial College London, London, UK

Roel Vermeulen

Utrecht University, Institute for Risk Assessment Sciences, Utrecht, the Netherlands; University Medical Center Utrecht, Julius Center, the Netherlands

Anssi Auvinen

STUK – Radiation and Nuclear Safety Authority, Environmental Surveillance, Vantaa, Finland; Tampere University, Faculty of Social Sciences/Health Sciences, Tampere, Finland

Aslak Harbo Poulsen

Danish Cancer Institute, Copenhagen, Denmark

Isabelle Deltour

International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France

Rachel B. Smith

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Medical Research Council (MRC) Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; National Institute for Health Research (NIHR) Health Protection Research Unit in Chemical and Radiation Threats and Hazards, Imperial College London, London, UK; Mohn Centre for Children’s Health and Wellbeing, School of Public Health, Imperial College London, London, UK

Joel Heller

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK

Hans Kromhout

Utrecht University, Institute for Risk Assessment Sciences, Utrecht, the Netherlands

Anke Huss

Utrecht University, Institute for Risk Assessment Sciences, Utrecht, the Netherlands

Christoffer Johansen

CASTLE Cancer Late Effect Research Oncology Clinic, Center for Surgery and Cancer, Rigshospitalet, Copenhagen, Denmark

Giorgio Tettamanti

Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Paul Elliott

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Medical Research Council (MRC) Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; National Institute for Health Research (NIHR) Health Protection Research Unit in Chemical and Radiation Threats and Hazards, Imperial College London, London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, London, UK; Corresponding authors at: Maria Feychting, Institute of Environmental Medicine, Box 210, SE-17177 Stockholm, Sweden (M. Feychting). Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, White City campus, 80 Wood Lane, London W12 0BZ, UK (P. Elliott).